In this study, we propose to examine the interaction of this virus with the immune system of dogs, including assessing any potential increase
in immune response to the tumor.
While higher TIL levels conferred a favorable prognosis in patients with spontaneous
immune response to tumor antigens, they were a poor prognostic factor in patients who did not experience an immune response.
«Our findings suggest that genetically altering tumor cells to produce IL - 15 and IL - 15Rα can cause and
enhance immune responses to tumor antigens found in these tumor cells and can be used as a vaccine to target these antigens.
Dr. Gnjatic's research focuses on human antigen -
specific immune responses to tumor antigens, in an attempt to define new targets for the development of cancer immunotherapies, assess the efficacy of these immunotherapies, and learn why they may fail.
In this study, we examined the effectiveness of a vaccination targeting tumors that produced IL - 15 and its cell surface receptor called IL - 15R - alpha -LRB--RRB- and examined their ability to up - regulate (or increase)
immune responses to tumor antigens,» Morris says.
«Jumbled chromosomes may dampen
the immune response to tumors.»
«Even a small amount of infection with oHSV appears to be enough to trigger
an immune response to the tumor.»
«We wanted to establish whether we can actually elicit
an immune response to a tumor growing within the brain,» explains Burkhard Becher.
Recent scientific breakthroughs in the understanding of
the immune response to tumors have led to the identification of cell molecular pathways that control immune response.
The Pexa - Vec virus was originally developed by Michael Mastrangelo, MD, and Edmund Lattime, PhD, of Thomas Jefferson University in Philadelphia, who engineered the harmless vaccinia virus to infect only cancer cells and other rapidly dividing cells, as well as to stimulate immune activity, in hopes of boosting
the immune response to tumors.
It will also measure
the immune response to tumor cells and characterize the therapeutic consequences of escalating doses of the study drug.
This reinforced
the immune response to tumors, fungi and viruses (Gerson 1999).
While this virus was hypothesized to kill osteosarcoma cells through its replication, we have recently recognized the possibility that the virus stimulates
an immune response to tumor, in addition to itself.